Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,466 total articles
Taboola, a global leader in performance advertising technology, will be included in the Russell 3000 and Russell 2000 Indexes at the close of the June 2026 Russell Reconstitution. This inclusion reflects the company's strong business fundamentals and aims to enhance visibility among institutional investors, potentially supporting long-term sharehol…
Parsons Corporation secured a $28 million task order from the U.S. Air Force to provide comprehensive Field Site Support for the GARDEM 2 program. This award is part of multiple contracts won in 2026, bringing Parsons' total GARDEM-related awards to $218 million. Over five years, Parsons will deliver onsite training, system enhancements, testing, a…
Akamai Technologies announced a strategic partnership with GM Sectec to integrate advanced PCI compliance and cybersecurity solutions aimed at securing AI-driven autonomous digital workforces and strengthening defenses against ransomware and API-based threats. The collaboration focuses on pioneering agentic compliance, continuous API security, and …
Amaze Holdings, Inc. announces a partnership with country music label BBR Music Group to create a centralized merchandise storefront for artists. Using Amaze's print-on-demand platform, the collaboration aims to provide scalable, low-risk merchandising solutions and new revenue streams for artists by enabling rapid product design and launch without…
MannKind Corporation announced the completion of patient randomization in its Phase 1b INFLO-1 study and enrollment of the first patient in the global Phase 2 INFLO-2 trial for its inhaled nintedanib dry powder inhaler (DPI) targeting idiopathic pulmonary fibrosis (IPF). The Phase 1b data, expected in Q3 2026, will assess safety, tolerability, and …
OwlTing Group (NASDAQ: OWLS) announced securing a Money Transmitter License for Ohio, extending its OwlPay payment network coverage to 42 U.S. states. This strategic expansion enables OwlTing to serve one of the largest U.S. economies, rich in aerospace, defense, and manufacturing industries that rely heavily on cross-border payments. The license s…
Mineralys Therapeutics announced the pricing of a $150 million underwritten common stock offering at $26.50 per share, intending to use the proceeds toward repurchasing a $200 million royalty obligation from Tanabe Pharma Corporation and supporting its recent $500 million debt facility. The offering will close on June 4, 2026, subject to customary …
KBR's Mission Technology Solutions business has been awarded an $8 billion ceiling Indefinite Delivery Indefinite Quantity contract by the U.S. National Science Foundation to provide comprehensive operations, maintenance, logistics, and scientific support for the U.S. Antarctic Program over a 20-year period. The contract supports year-round scienti…
T1 Energy Inc., a US-based solar and battery solutions provider, announced the acquisition of KORE Power, a leader in battery energy storage systems (BESS) and software for industrial hyperscalers. The $32 million transaction, expected to close in Q2 2026, positions T1 to enter the growing energy storage and AI data center infrastructure markets. T…
Mineralys Therapeutics announced the repurchase of its royalty obligations under the Tanabe license agreement for lorundrostat with an upfront $200 million payment and up to $100 million upon commercial milestones. The company also secured a $500 million senior secured term loan facility and priced a $150 million common stock offering to strengthen…
Aclarion, a US healthcare technology company, has partnered with the Institute of Neuro Innovation, a leading neuroscience clinic in Los Angeles, to expand availability of its Nociscan platform. This collaboration aims to generate real-world evidence by comparing Nociscan's chemical biomarker data with SPECT-CT bone metabolic information, enhancing…
Yuanbao Inc., a leading technology-driven online insurance distributor in China, announced it will release its unaudited Q1 2026 financial results on June 10, 2026, before U.S. market open. The company will hold a conference call to discuss results, providing access details via online registration and webcast. Yuanbao leverages technology to delive…
GEN Restaurant Group, Inc., operator of GEN Korean BBQ, announced the appointment of Luke A. Hewko as Chief Financial Officer to lead financial strategy during its expansion into consumer packaged goods (CPG), retail, and online commerce. Hewko's extensive experience in scaling e-commerce businesses and financial operations positions GEN for effect…
Zhihu Inc., a leading Chinese online content community listed on NYSE and HKEX, reported its Q1 2026 financial results showing total revenues of RMB651.6 million (US$94.5 million), a decrease from the previous year. Despite the revenue drop, Zhihu narrowed its net loss by 15.6% to RMB8.5 million (US$1.2 million) and achieved a significant 147.2% in…
Zhihu Inc., a leading Chinese online content community listed on both NYSE and HKEX, announced a board change with the resignation of non-executive director Bing Yu and the appointment of Qu Chen to the position. Qu Chen brings extensive experience in strategic investment, capital markets, and business analysis, currently serving as Head of Busines…
Magnite, a leading independent sell-side advertising company, has extended its partnership with dentsu in Sweden to improve Connected TV (CTV) activation using Magnite's programmatic infrastructure and technology. This collaboration aims to accelerate innovation, streamline media buying, and enable data-driven scalable advertising solutions across …
Ferrari N.V. announces a multi-year renewal agreement with Charles Leclerc to remain an official driver for Scuderia Ferrari HP in upcoming Formula 1 World Championship seasons, securing key talent for the racing team.
STMicroelectronics has introduced the IIS3DWB10IS, a high-performance MEMS vibration sensor equipped with an Intelligent Sensor Processing Unit (ISPU 2.0) that integrates AI inference at the sensor level. This sensor offers a compelling alternative to traditional piezoelectric sensors by providing high accuracy, wide bandwidth, energy efficiency, a…
argenx SE presented long-term data for its FcRn blocker drug efgartigimod, showing sustained clinical improvements and favorable safety profiles in patients with myositis and Sjogren's disease. Data from ongoing extension studies ALKIVIA+ and RHO+ demonstrate maintained disease activity reduction and tolerability over 52 and 72 weeks respectively. …
SEALSQ Corp, a US-listed leader in post-quantum semiconductor technologies, has participated as a lead investor in Quobly’s €130 million Series A financing round, alongside ST Microelectronics and other investors. This investment, made via SEALSQ's Quantum Fund, supports Quobly's efforts to industrialize silicon-based quantum processors and the dep…
Astera Labs, Inc., a Nasdaq-listed company specializing in semiconductor connectivity solutions for AI infrastructure, announced a major expansion of its Taiwan operations and Cloud-Scale Interop Lab. This move strengthens engineering collaboration, system integration, and validation efforts with key AI platform providers and ODM partners in Taiwan…
Figure Technology Solutions disclosed preliminary unaudited operating data for May 2026, highlighting a 135% year-over-year increase in Consumer Loan Marketplace Volume to $1.402 billion and sequential growth in $YLDS token circulation. The company emphasized its leadership in blockchain-native capital marketplaces, including its flagship products …
DBV Technologies has announced the screening of the first participant in its THRIVE Phase 2 clinical trial evaluating the safety and efficacy of the VIASKIN® Peanut Patch in infants aged 6 to 12 months with peanut allergy. This study builds on prior positive results in older children and aims to explore early intervention potential in the youngest …
Zenas BioPharma announced positive Phase 3 INDIGO trial results for obexelimab in treating Immunoglobulin G4-Related Disease (IgG4-RD). The trial met its primary and all key secondary endpoints with statistically significant reductions in disease flare risk, glucocorticoid use, and related toxicities. Obexelimab demonstrated a favorable safety prof…
Apollo Global Management announced the completion of the sale of its interest in ALTEMIRA Holdings Co., Ltd., a leading pan-Asian aluminum packaging company, to funds managed by MBK Partners. ALTEMIRA, established through consolidation of former aluminum businesses of Showa Denko and Mitsubishi Materials, operates a vertically integrated aluminum r…
